Immune-related adverse events after a single dose of pembrolizumab

被引:1
|
作者
Vos, Hanne [1 ]
Lambein, Kathleen [1 ]
Wildiers, Hans [2 ,3 ]
Punie, Kevin [2 ,3 ]
Smeets, Ann [1 ,2 ]
机构
[1] Katholieke Univ Leuven, Dept Oncol, Univ Hosp Leuven, Dept Surg Oncol, Leuven, Belgium
[2] Univ Hosp Leuven, Multidisciplinary Breast Ctr, Leuven, Belgium
[3] Univ Hosp Leuven, Dept Gen Med Oncol, Leuven, Belgium
关键词
D O I
10.1016/j.ejca.2021.01.048
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页码:92 / 94
页数:3
相关论文
共 50 条
  • [21] Immune-related adverse events after immune checkpoints inhibitors in 2019: An update
    Comont, T.
    Belliere, J.
    Sibaud, V.
    Alric, L.
    Meyer, N.
    Mazieres, J.
    Caron, P.
    Acket, B.
    Michot, J. -M.
    Beyne-Rauzy, O.
    Lambotte, O.
    REVUE DE MEDECINE INTERNE, 2020, 41 (01): : 37 - 45
  • [22] Recurrence of Immune-Related Adverse Events After Immune Checkpoint Inhibitor Rechallenge
    Liu, Jie
    Yu, Jinming
    Meng, Xue
    JAMA ONCOLOGY, 2020, 6 (11) : 1813 - +
  • [23] Immune-Related Adverse Events: Development of a Pilot Immune-Related Adverse Events Clinic for Expedited and Effective Patient Care
    Reid, Pankti
    Jan, Reem
    ARTHRITIS & RHEUMATOLOGY, 2018, 70
  • [24] Associations between tumor response to pembrolizumab and immune-related adverse events in metastatic melanoma patients
    Geszti, F.
    Czirbesz, K.
    Kenessey, I.
    Liszkay, G.
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2019, 81 (04) : AB24 - AB24
  • [25] Risk factors for immune-related adverse events associated with anti-PD-1 pembrolizumab
    Eun, Yeonghee
    Kim, In Young
    Sun, Jong-Mu
    Lee, Jeeyun
    Cha, Hoon-Suk
    Koh, Eun-Mi
    Kim, Hyungjin
    Lee, Jaejoon
    SCIENTIFIC REPORTS, 2019, 9 (1)
  • [26] Risk factors for immune-related adverse events associated with anti-PD-1 pembrolizumab
    Yeonghee Eun
    In Young Kim
    Jong-Mu Sun
    Jeeyun Lee
    Hoon-Suk Cha
    Eun-Mi Koh
    Hyungjin Kim
    Jaejoon Lee
    Scientific Reports, 9
  • [27] Atherosclerotic Progression Is Related to Immune-Related Adverse Events
    Kurozumi, Atsumasa
    Sakamoto, Kayo
    Nakagawa, Takashi
    Matsunaga, Futoshi
    Shimomura, Akihiko
    Shimizu, Chikako
    Hara, Hisao
    Hiroi, Yukio
    INTERNATIONAL HEART JOURNAL, 2022, 63 (02) : 293 - 298
  • [28] Clinical assessment of immune-related adverse events
    Sosa, Aaron
    Lopez Cadena, Esther
    Simon Olive, Cristina
    Karachaliou, Niki
    Rosell, Rafael
    THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY, 2018, 10
  • [29] Immune-related adverse events: A bibliometric analysis
    Jiang, Shi-Tao
    Liu, Yao-Ge
    Zhang, Lei
    Sang, Xin-Ting
    Xu, Yi-Yao
    Lu, Xin
    FRONTIERS IN IMMUNOLOGY, 2022, 13
  • [30] Immune-related adverse events of checkpoint inhibitors
    Ramos-Casals, Manuel
    Brahmer, Julie R.
    Callahan, Margaret K.
    Flores-Chavez, Alejandro
    Keegan, Niamh
    Khamashta, Munther A.
    Lambotte, Olivier
    Marlette, Xavier
    Prat, Aleix
    Suarez-Almazor, Maria E.
    NATURE REVIEWS DISEASE PRIMERS, 2020, 6 (01)